PN-881: First-in-class oral peptide targeting the IL-17 pathway Manrique M, et al
2025 Society For Investigative Dermatology
calendar_today
May 7, 2025
domain
protagonist-therapeutics
Need help?
Contact usPN-881: First-in-class oral peptide targeting the IL-17 pathway Manrique M, et al